Teva Pharma Stock Target Price and Analyst Consensus

TEVA Stock  USD 14.06  0.37  2.56%   
The current analyst and expert consensus on Teva Pharma is Strong Buy with 5 hold recommendations. The current projected Teva Pharma target price consensus is 10.56 with 13 analyst opinions. One of the most common ways Teva Pharma Industries analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Teva Pharma vendors, executives, and/or customers. Teva Pharma recommendation module provides expert sentiment on the projected Teva Pharma Industries target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Teva Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
9.61
Highest Forecast
11.72
Target Price
10.56
As of March 28, 2024, Gross Profit is expected to decline to about 4.8 B. The current year's Pretax Profit Margin is expected to grow to -0.04. At present, Teva Pharma's Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.6 B, whereas Total Assets are forecasted to decline to about 26.4 B.
  
It's important to approach Teva Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Teva Pharma Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teva target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Teva Pharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   13  Strong Buy
Most Teva analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Teva stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Teva Pharma Industries, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Teva Pharma Target Price Projection

Teva Pharma's current and average target prices are 14.06 and 10.56, respectively. The current price of Teva Pharma is the price at which Teva Pharma Industries is currently trading. On the other hand, Teva Pharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Teva Pharma Market Quote on 28th of March 2024

Low Price14.06Odds
High Price14.06Odds

14.06

Target Price

Analyst Consensus On Teva Pharma Target Price

Low Estimate9.61Odds
High Estimate11.72Odds

10.56

Historical Lowest Forecast  9.61 Target Price  10.56 Highest Forecast  11.72
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Teva Pharma Industries and the information provided on this page.

Teva Pharma Analyst Ratings

Teva Pharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Teva Pharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Teva Pharma's financials, market performance, and future outlook by experienced professionals. Teva Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Teva Pharma price targets

Teva Pharma's stock target price is an estimate of its future price, usually made by analysts. Using Teva Pharma's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Teva Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Teva Pharma's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Teva Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Teva Pharma is a key component of Teva Pharma valuation and have some predictive power on the future returns of a Teva Pharma.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.7414.5016.26
Details
Intrinsic
Valuation
LowRealHigh
11.4613.2214.98
Details
Naive
Forecast
LowNextHigh
13.1014.8716.63
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.540.580.61
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Teva Pharma. Your research has to be compared to or analyzed against Teva Pharma's peers to derive any actionable benefits. When done correctly, Teva Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Teva Pharma Industries.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested a lot of shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:
Check out Macroaxis Advice on Teva Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Teva Stock analysis

When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
The data published in Teva Pharma's official financial statements usually reflect Teva Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Teva Pharma Industries. For example, before you start analyzing numbers published by Teva accountants, it's critical to develop an understanding of what Teva Pharma's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Teva Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Teva Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Teva Pharma Industries. Please utilize our Beneish M Score to check the likelihood of Teva Pharma's management manipulating its earnings.